Masimo Corporation
Proven technology, proven performance, proven leadership
For more than 20 years, Masimo has focused on a singular mission—to help clinicians improve patient outcomes and reduce cost of care by taking noninvasive monitoring to new sites and applications. The result is a portfolio of clinically proven products that lead the way in innovation, performance and patient safety.
At A GlanceAddress40 Parker ProductsMasimo SET Measure-through Motion and Low Perfusion pulse oximeters and sensors; Masimo rainbow Pulse CO-Oximeters and sensors; Masimo rainbow Acoustic monitors and sensors; SEDLine brain function monitoring; and Patient SafetyNet. Mission StatementImproving patient outcomes and reducing cost of care by taking noninvasive monitoring to new sites and applications. Employees2,000+ Chairman and CEOJoe Kiani |
Gold-standard Pulse Oximetry With Masimo SET®
Masimo Signal Extraction Technology (Masimo SET) is the world’s leading pulse oximetry technology, proven by both objective research and the real-world success of customers and partners. More than 100 independent, peer-reviewed studies have shown that Masimo SET outperforms all other pulse oximetry technologies, providing clinicians with unmatched sensitivity and specificity to make critical patient care decisions even under the most demanding clinical conditions of motion and low perfusion.
rainbow® Acoustic Monitoring™ for Continuous and Noninvasive Respiration Rate
Masimo rainbow Acoustic Monitoring provides continuous and noninvasive Acoustic Respiration Rate (RRa™) that is accurate, easy to use and patient tolerant. Featuring an innovative adhesive sensor with an integrated acoustic transducer that is easily and comfortably applied to the patient’s neck, rainbow Acoustic Monitoring captures, separates and processes the respiratory signal using Masimo’s patented Signal Extraction Technology.
rainbow Pulse CO-Oximetry for Continuous and Noninvasive Hemoglobin Monitoring
Continuous and noninvasive total hemoglobin (SpHb®) is part of the Masimo rainbow SET technology platform—a breakthrough noninvasive blood constituent monitoring platform that measures physiological parameters that previously required invasive blood sampling and time-consuming laboratory analysis.
Masimo SpHb helps clinicians trend hemoglobin status to enable real-time patient management decisions. In fact, a randomized controlled trial at a major U.S. teaching hospital showed that clinicians using Masimo SpHb reduced the frequency of intraoperative blood transfusions from 4.5% to 0.6% (Ehrenfeld JM, et al. American Society of Anesthesiologists 2010 annual meeting: LB05).
In addition to SpHb, the upgradable rainbow platform allows clinicians to measure oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®) and pleth variability index (PVI®), as well as oxygen saturation (SpO2), pulse rate (PR) and perfusion index (PI). PVI has been shown to help clinicians assess fluid responsiveness and improve fluid management to reduce patient risk (Cannesson M, et al. Br J Anesth 2008;101:200-206. Forget P, et al. Anesth Analg 2010;111:910-914).
SEDLine® Brain Function Monitoring
SEDLine brain function monitoring advances neuromonitoring technologies to improve the care of patients under anesthesia or sedation. The core product is a state-of-the-art electroencephalogram (EEG)-based brain function monitor. Using four channels of information, the SEDLine monitor measures the effects of anesthesia and sedation by monitoring both sides of the brain’s electrical activity to enable more individualized titration that helps to enhance anesthetic control throughout all phases of anesthesia.
Patient SafetyNet™
The Patient SafetyNet system combines gold-standard Masimo SET pulse oximetry, breakthrough rainbow measurements and remote patient monitoring with wireless clinician alerts—providing an unmatched level of patient safety on general care floors. The system can either be integrated into an existing IT infrastructure or operate as a standalone system.
For many years, clinicians have understood the risk of not continuously monitoring patients on the general floor. However, excessive false alarms due to patient motion made general floor monitoring an elusive goal. Multiple studies over the last decade have shown that Masimo SET improves the process of care in neonates and pediatric patients—but a recent landmark study was the first to show that Masimo SET improves clinical outcomes in adults. After implementing Masimo SET and Patient SafetyNet in a postsurgical floor where only intermittent spot checking had been used before, a major academic medical center significantly reduced rescue events by 65%, intensive care unit (ICU) transfers by 48% and annualized ICU bed usage by 135 days with no sentinel events (Taenzer AH, et al. Anesthesiology 2010;112:282-287).
Just as pulse oximetry is a standard of care in the operating room, postanesthesia care unit and ICU, we now believe that pulse oximetry will become a standard of care on the general floor. When rainbow Acoustic Monitoring is used in conjunction with rainbow Pulse CO-Oximetry and Patient SafetyNet, clinicians can follow key indicators of oxygenation, ventilation, circulation and bleeding—enabling them to monitor more patients, more safely than ever before.
This corporate profile was reviewed and approved by Masimo Corporation.